Emerson Acquires Fluxa (after earlier equity investment)

February 25, 2021

Emerson (NYSE: EMR) initially made an equity investment in Fluxa in February 2021 to accelerate the development and commercialization of Fluxa’s Process & Knowledge Management (PKM) life‑sciences software. Emerson later completed a full acquisition of Fluxa (announced June 30, 2022) to integrate Fluxa’s PKM capabilities with Emerson’s life‑sciences automation and execution systems.

Buyers
Emerson
Targets
Fluxa
Industry
Software
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.